Skip to Main Content
Qurgen Qurgen
Menu Button

Dec. 2023

Brand Icon
Suzhou Fuent Pharmaceutical Co., Ltd. received an additional investment of 50 million RMB, valuing the company at 625 million RMB after the supplementary investment.

Recent important news

Mar. 2026
Qurgen is happy to announce that the blood and biopsy tissue results of a late-stage of ocular melanoma...
Learn More
Jan. 13, 2026
Dr. Chai Yan Joins Qurgen/Fuent as Senior Vice President for BP，Qurgen, CEO，Suzhou Fuent Pharmaceutics and...
Learn More